Acadia Healthcare reported adjusted EPS of $0.38 for Q2, topping the $0.35 consensus, while revenue held steady at $865.8 million. The beat underscores the company’s ability to generate cash and expand capacity, supporting its upgraded 2026 outlook and giving investors confidence in continued growth.
Key Highlights
- Adjusted EPS $0.38 beats estimate; revenue $865.8 M flat year‑over‑year
- Operating cash flow rises to $162.1 M; capital expenditures cut to $38.6 M
- Added new licensed beds through two joint‑venture facilities
Revenue in the period measured $865.8 million, essentially unchanged from the prior year after normalizing for supplemental payment timing, while same‑facility patient days nudged up 0.8% and revenue per patient day fell 0.8%.
EPS Beats Consensus
The $0.38 adjusted EPS represents a clear outperformance that signals the firm’s resilience in a challenging reimbursement environment. Adjusted net income reached $35.1 million, compared with $74.8 million a year earlier, and adjusted EBITDA slipped to $149.2 million from $201.8 million. These figures, while lower than the prior period, still reflect sizable cash generation, as operating cash flows climbed to $162.1 million versus $133.5 million a year ago.
The earnings beat, coupled with strong cash flow, bolsters the company’s capacity to fund upcoming projects without diluting equity, a point that should reassure capital‑intensive investors.
Operational Performance
Revenue of $865.8 million, after normalizing for supplemental payment timing, grew 2.8% quarter‑over‑quarter. Expenses increased, driven largely by a $28.6 million increase in professional and general liability reserves. Salaries, wages, and benefits grew modestly, reflecting disciplined cost control even as the company expanded capacity.
Both sites are now operational, enhancing the firm’s footprint in acute inpatient psychiatric care. Capital expenditures were sharply trimmed to $38.6 million from $167.7 million a year earlier, reflecting the completion of earlier expansion phases and a shift toward operational efficiency. The continued expansion of bed capacity positions the company to capture rising demand for behavioral health services, a sector still buoyed by demographic trends.
Market Reaction
& Outlook The company upgraded its full‑year 2026 guidance, reflecting confidence in continued revenue and earnings growth. The next catalyst is the earnings conference call scheduled for July 29, when management will discuss the outlook and address analyst questions, a key event for investors tracking execution risk.
Peers Moving on This News
- Universal Health Services Inc (UHS) up 0.8%
- Pacs Group Inc (PACS) down 1.0%
- Concentra Group Holdings Parent Inc (CON) up 1.2%
Analysis based on the Form 8-K filed 28 July 2026; figures verified against the filing and live market data.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.






Please wait processing your request...